Stay updated on Nivolumab & Ipilimumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.

Latest updates to the Nivolumab & Ipilimumab in Melanoma Clinical Trial page
- Check6 days agoChange DetectedA new revision tag v3.6.3 is now shown, replacing v3.6.2, signaling a minor update to the page's revision history without substantive changes to the study information.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, reflecting a newer build of the page.SummaryDifference0.0%

- Check20 days agoChange DetectedDeleted the Bristol-Myers Squibb clinical trial educational resource from the Study Details page, removing access to the trial's educational materials.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page now clearly indicates that the study is no longer recruiting participants. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading and a site revision tag (Revision: v3.6.0).SummaryDifference0.4%

- Check35 days agoChange DetectedFooter site revision updated from v3.5.4 to v3.5.5, indicating a new release of the page template. No study details or actions are affected; this is an internal maintenance update.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, signaling a new build/deployment of the page.SummaryDifference0.1%

Stay in the know with updates to Nivolumab & Ipilimumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.